2016 ASCO poster search results 'ovarian cancer' = 77 Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, June 12, 2016

2016 ASCO poster search results 'ovarian cancer' = 77



search results (77)

Site

Search returned 77 results for “ovarian cancer”

  1. Poster

    2016 ASCO Annual Meeting Poster Session Glucocorticoid receptor expression and survival in ovarian cancer.
    Author(s): Jennifer Taylor Veneris
    June 3, 2016
  2. Poster

    2016 ASCO Annual Meeting Poster Discussion Session Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing.
    Author(s): Kenneth Offit
    June 3, 2016
  3. Poster

    2016 ASCO Annual Meeting Poster Session Validation of a multi-marker panel for early detection of ovarian cancer.
    Author(s): Robert C. Bast
    June 3, 2016
  4. Poster

    2016 ASCO Annual Meeting Poster Session Universal germline BRCA testing of ovarian cancer patients and implications for treatment.
    Author(s): Erica Bednar
    Associated Content: Slides || Poster
    June 3, 2016
  5. Poster

    2016 ASCO Annual Meeting Poster Session The impact of preoperative malnutrition on surgery outcome and overall survival in ovarian or peritoneal cancer patients. A prospective study.
    Author(s): Jalid Sehouli
    June 3, 2016

  6. Poster

    2016 ASCO Annual Meeting Poster Session Circulating cell-free DNA: The future of personalized medicine in ovarian cancer management.
    Author(s): Rebecca Christian Arend
    June 3, 2016
  7. Poster

    2016 ASCO Annual Meeting Poster Session P53 functional mutation type in high grade serous ovarian cancer and clinical outcomes.
    Author(s): Victoria Mandilaras
    June 3, 2016
  8. Poster

    2016 ASCO Annual Meeting Poster Session Endocrine therapy for ovarian cancer: A systematic review and meta-analysis of phase II studies.
    Author(s): Laura Paleari
    June 3, 2016
  9. Poster

    2016 ASCO Annual Meeting Poster Session A Phase Ib study of Acelarin and carboplatin for patients with recurrent ovarian cancer.
    Author(s): Sarah Patricia Blagden
    June 3, 2016
  10. Poster

    2016 ASCO Annual Meeting Poster Session An evaluation of the microbiota of the upper genital tract of women with benign changes and epithelial ovarian cancer.
    Author(s): Wendy R. Brewster
    Associated Content: Slides || Poster
    June 3, 2016
  11. Poster

    2016 ASCO Annual Meeting Poster Session Prognostic effects of peripheral and tumor-infiltrating T-cell repertoire diversity in ovarian cancer.
    Author(s): Kunle Odunsi
    Associated Content: Slides || Poster
    June 3, 2016
  12. Poster

    2016 ASCO Annual Meeting Poster Session Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: Colorectal cancer survival by trial arm.
    Author(s): Maryam Doroudi
    June 3, 2016
  13. Poster

    2016 ASCO Annual Meeting Poster Session Randomized trial of exercise vs. usual care on cancer biomarkers in ovarian cancer survivors: The Women’s Activity and Lifestyle Study in Connecticut (WALC).
    Author(s): Brenda Cartmel
    June 3, 2016
  14. Poster

    2016 ASCO Annual Meeting Poster Session A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Platinum Resistant Ovarian Cancer.
    Author(s): Agustin A. Garcia
    June 3, 2016
  15. Poster

    2016 ASCO Annual Meeting Poster Session Evolution in epithelial ovarian cancer (OC) trials: Improving accuracy by design.
    Author(s): Michelle K. Wilson
    June 3, 2016
  16. Poster

    2016 ASCO Annual Meeting Poster Session Phase II study of everolimus (EV) and bevacizumab (BEV) in recurrent ovarian, peritoneal, and fallopian tube cancer.
    Author(s): Sarah E Taylor
    June 3, 2016
  17. Poster

    2016 ASCO Annual Meeting Poster Session Germline and somatic homologous recombination gene mutations in high-grade serous ovarian cancer and clinical outcome.
    Author(s): Victoria Mandilaras
    June 3, 2016
  18. Poster

    2016 ASCO Annual Meeting Poster Session MC1463: Avatar-directed chemotherapy in platinum-resistant ovarian cancer.
    Author(s): Beverly Long
    June 3, 2016
  19. Poster

  20. Poster

    2016 ASCO Annual Meeting Poster Discussion Session Immunogenicity of clear cell ovarian cancer: Association with ARID1A loss, microsatellite instability and endometriosis.
    Author(s): Kyle Strickland
    Associated Content: Slides || Poster
    June 3, 2016

Pages

0 comments :

Post a Comment

Your comments?